Banco Bilbao Vizcaya Argentaria S.A. Purchases 32,609 Shares of Teladoc Health, Inc. $TDOC

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. has increased its stake in Teladoc Health, Inc. by 23.2%, now owning approximately 172,977 shares valued at around $1.39 million.
• Several institutional investors have significantly boosted their investments in Teladoc Health, with Golden State Wealth Management increasing its stake by 102.6% in the first quarter alone.
• Recent analyst ratings on Teladoc Health reflect a mixed sentiment, with a consensus "Hold" rating and varying price targets, ranging from $8.00 to $12.00.

Banco Bilbao Vizcaya Argentaria S.A. grew its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 23.2% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 172,977 shares of the health services provider's stock after buying an additional 32,609 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. owned approximately 0.10% of Teladoc Health worth $1,389,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cambridge Investment Research Advisors Inc. raised its position in shares of Teladoc Health by 60.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock valued at $316,000 after buying an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares during the last quarter. Wedmont Private Capital raised its position in shares of Teladoc Health by 20.3% during the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock valued at $117,000 after buying an additional 2,715 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Teladoc Health by 22.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after buying an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. raised its position in shares of Teladoc Health by 61.4% during the first quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock valued at $171,000 after buying an additional 8,152 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Price Performance

NYSE TDOC traded down $0.01 on Thursday, reaching $7.74. The company's stock had a trading volume of 1,167,869 shares, compared to its average volume of 6,889,500. The firm has a market cap of $1.37 billion, a PE ratio of -6.48 and a beta of 1.76. The business has a 50-day moving average price of $7.77 and a 200 day moving average price of $8.14. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm's revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Sell-side analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Ratings Changes

TDOC has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Truist Financial cut their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. The Goldman Sachs Group cut their price objective on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Wells Fargo & Company lowered their target price on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 8th. Finally, Mizuho assumed coverage on shares of Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, Teladoc Health has a consensus rating of "Hold" and an average price target of $9.80.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the sale, the insider directly owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Fernando M. Rodrigues sold 4,174 shares of the company's stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.